<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1 20151215//EN" "https://jats.nlm.nih.gov/publishing/1.1/JATS-journalpublishing1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" specific-use="sps-1.9" dtd-version="1.1" xml:lang="pt" article-type="research-article">
  <front>
    <journal-meta>
      <journal-id journal-id-type="publisher-id">abc</journal-id>
      <journal-title-group>
        <journal-title>Arquivos Brasileiros de Cardiologia</journal-title>
        <abbrev-journal-title abbrev-type="publisher">Arq. Bras. Cardiol.</abbrev-journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0066-782X</issn>
      <issn pub-type="epub">1678-4170</issn>
      <publisher>
        <publisher-name>Sociedade Brasileira de Cardiologia - SBC</publisher-name>
        <publisher-loc>S&#227;o Paulo, SP, Brazil</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="publisher-id" specific-use="scielo-v3">58JFnTXVWT3TCR7Q7YPtGyy</article-id>
      <article-id pub-id-type="other">00004</article-id>
      <article-id pub-id-type="publisher-id" specific-use="scielo-v2">S0066-782X1998000400004</article-id>
      <article-id pub-id-type="publisher-id" specific-use="scielo-v1">S0066-782X(98)07000404</article-id>
      <article-id pub-id-type="doi">10.1590/S0066-782X1998000400004</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Artigos Originais</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Hemograma, s&#243;dio, pot&#225;ssio, c&#225;lcio, osmolalidade e viscosidade durante angiocardiografia pedi&#225;trica com ioxaglato</article-title>
        <trans-title-group xml:lang="en">
          <trans-title>Blood cell count, sodium, potassium, calcium, osmolality and viscosity, during pediatric angiocardiography with ioxaglate</trans-title>
        </trans-title-group>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Moura</surname>
            <given-names>Mauro Regis Silva</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Leboute</surname>
            <given-names>Fl&#225;vio</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Gottschall</surname>
            <given-names>Carlos Antonio Mascia</given-names>
          </name>
        </contrib>
      </contrib-group>
      <pub-date date-type="collection" publication-format="electronic">
        <month>04</month>
        <year>1998</year>
      </pub-date>
      <volume>70</volume>
      <issue>4</issue>
      <fpage>257</fpage>
      <lpage>264</lpage>
      <history>
        <date date-type="accepted">
          <day>04</day>
          <month>02</month>
          <year>1998</year>
        </date>
        <date date-type="received">
          <day>07</day>
          <month>01</month>
          <year>1998</year>
        </date>
      </history>
      <permissions>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/4.0/" xml:lang="en">
          <license-p>This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.</license-p>
        </license>
      </permissions>
      <abstract>
        <p>OBJETIVO: Os meios de contraste (MC) introduzem altera&#231;&#245;es em alguns par&#226;metros sang&#252;&#237;neos, adquirindo, assim, mais import&#226;ncia na angiocardiografia pedi&#225;trica. M&#201;TODOS: Estudamos a presen&#231;a e a severidade das mudan&#231;as no hemat&#243;crito, hemoglobina, leuc&#243;citos, s&#243;dio, pot&#225;ssio, c&#225;lcio, osmolalidade e viscosidade, em 35 crian&#231;as submetidas a angiocardiografia com ioxaglato, identificando, tamb&#233;m, as vari&#225;veis independentes respons&#225;veis por essas altera&#231;&#245;es. As amostras sang&#252;&#237;neas foram colhidas no in&#237;cio do procedimento (S1), no fim (S2) e 2h ap&#243;s (S3). RESULTADOS: Hemat&#243;crito: S1= 47,3&#177;6,9%; S2= 40,7&#177;7,4% (p&lt;0,001) (relacionado com o ioxaglato r=0,37, p&lt;0,05). Hemoglobina: S1= 15&#177;2,1g%; S2= 13,2&#177;2,4g% (p&lt;0,001). Leuc&#243;citos: S1= 7940&#177;3040 leuc&#243;citos/mm&#179;; S2= 6950&#177; 2700/mm&#179; (NS); S3= 10830&#177; 4690, (p&lt;0,001). Identificamos a dura&#231;&#227;o do procedimento (r=0,38, p&lt;0,05) e o volume total de soro glicosado (r=0,49, p&lt;0,05). S&#243;dio: S1= 134,5&#177;0,4mEq/L; S2= 130,7&#177;0,4mEq/L (p&lt;0,001) relacionado &#224; solu&#231;&#227;o glicosada (r=0,61, p&lt;0,01). Pot&#225;ssio: S1= 4,22&#177; 0,45mEq/L; S2= 3,83&#177;0,4mEq/L (p&lt;0,001). Nenhuma vari&#225;vel foi isolada. C&#225;lcio; S1= 9,13&#177;1,03mg%; S2= 8,4&#177;0,91mg% (relacionado ao ioxaglato r=0,43, p&lt;0,01). Osmolalidade: S1= 293,3&#177;12,5mOsm/kg; S2= 300,6&#177;13,3mOsm/kg (p&lt;0,001). Nenhuma das vari&#225;veis independentes foi isolada. Viscosidade: S1= 3,36&#177;0,81; S2= 3,09&#177;0,74 (p&lt;0,01); S3= 3,87&#177;0,89, p&lt;0,001 (devido a uma regress&#227;o linear indireta com o MC). CONCLUS&#195;O: Varia&#231;&#245;es significativas nas vari&#225;veis dependentes medidas foram observadas durante e ap&#243;s o procedimento. O uso do ioxaglato foi parcialmente relacionado a mudan&#231;as no hemat&#243;crito/hemoglobina, c&#225;lcio total e viscosidade mas n&#227;o as das vari&#225;veis restantes.</p>
      </abstract>
      <trans-abstract xml:lang="en">
        <p>PURPOSE: Children's blood changes during angiocardiography may not be only due to the contrast media (CM). METHODS: We studied the presence and severity of changes in those parameters in 35 pediatric patients undergoing angiocardiography with ioxaglate aiming to identify independent variables responsible for those changes. Blood samples were taken at the beginning of the procedure (S1), at the end (S2) and two hours later (S3). RESULTS: Hematocrit: S1= 47.3&#177;6.9%; S2= 40.7&#177; 7.4% (p&lt;0.001), (related to the CM volume r=0.37, p&lt;0.05). Hemoglobin: S1= 15&#177;2.1g%; S2= 13.2&#177;2.4g% (p&lt;0.001), and S3= 12.7&#177;2.5g% (NS). White blood cell count: S1= 7940&#177;3040 leukocytes/mm&#179;; S2= 6950&#177; 2700/mm&#179; (NS); S3= 10830&#177;4690 leukocytes/mm&#179;, (p&lt;0.001). Procedure duration (r=0.38, p&lt;0.05) and 5% glucose fluid given between S2 and S3 (r=0.49, p&lt;0.05) were isolated. Sodium: S1= 134.5&#177;0.4mEq/L; S2= 130.7&#177;0.4mEq/L (p&lt;0.001) (due to 5% glucose fluid injected, r=0.61, p&lt;0.01). Potassium: S1= 4.22&#177;0.45mEq/L, S2= 3.83&#177;0.4mEq/L (p&lt;0.001). Calcium: S1= 9.13&#177; 1.03mg%; S2= 8.4&#177;0.91mg/dL. (related to the CM, r=0.43, p&lt;0.01.) Osmolality: S1= 293.3&#177;12.5mOsm/kg; S2= 300.6&#177;13.3mOsm/kg (p&lt;0.001). Viscosity: S1= 3.36&#177;0.81; S2= 3.09&#177;0.74 (p&lt;0.01); S3= 3.87&#177;0.89, p&lt;0.001. There was an indirect linear regression with the CM. CONCLUSION: There were profound differences among the dependent variables observed but the ioxaglate was partially related to changes in hematocrit/ hemoglobin, total calcium and viscosity. We failed to demonstrate significant regression coefficient between CM and changes in leukocytes, sodium, potassium, and osmolality.</p>
      </trans-abstract>
      <kwd-group xml:lang="en" kwd-group-type="author-generated">
        <kwd>contrast media</kwd>
        <kwd>angiocardiography</kwd>
        <kwd>heart catheterization</kwd>
        <kwd>pediatric cardiology</kwd>
      </kwd-group>
      <kwd-group xml:lang="pt" kwd-group-type="author-generated">
        <kwd>meios de contraste</kwd>
        <kwd>angiocardiografia</kwd>
        <kwd>cardiologia pedi&#225;trica</kwd>
      </kwd-group>
      <pub-date publication-format="electronic" date-type="pub">
        <day>08</day>
        <month>01</month>
        <year>2002</year>
      </pub-date>
    </article-meta>
  </front>
  <body>
    <p>
      <bold>Artigo Original </bold>
    </p>
    <p>
      <bold>Hemograma, S&#243;dio, Pot&#225;ssio, C&#225;lcio, Osmolalidade e Viscosidade durante Angiocardiografia Pedi&#225;trica com Ioxaglato</bold>
    </p>
    <p>Mauro Regis Silva Moura, Fl&#225;vio Leboute, Carlos Antonio Mascia Gottschall </p>
    <p>
      <bold>Porto Alegre, RS </bold>
    </p>
    <p><bold><italic>OBJETIVO: </italic></bold>Os meios de contraste (MC) introduzem altera&#231;&#245;es em alguns par&#226;metros sang&#252;&#237;neos, adquirindo, assim, mais import&#226;ncia na angiocardiografia pedi&#225;trica. </p>
    <p><bold><italic>M&#201;TODOS: </italic></bold>Estudamos a presen&#231;a e a severidade das mudan&#231;as no hemat&#243;crito, hemoglobina, leuc&#243;citos, s&#243;dio, pot&#225;ssio, c&#225;lcio, osmolalidade e viscosidade, em 35 crian&#231;as submetidas a angiocardiografia com ioxaglato, identificando, tamb&#233;m, as vari&#225;veis independentes respons&#225;veis por essas altera&#231;&#245;es. As amostras sang&#252;&#237;neas foram colhidas no in&#237;cio do procedimento (S1), no fim (S2) e 2h ap&#243;s (S3). </p>
    <p><bold><italic>RESULTADOS: </italic></bold>Hemat&#243;crito: S1= 47,3&#177;6,9%; S2= 40,7&#177;7,4% (p&lt;0,001) (relacionado com o ioxaglato r=0,37, p&lt;0,05). Hemoglobina: S1= 15&#177;2,1g%; S2= 13,2&#177;2,4g% (p&lt;0,001). Leuc&#243;citos: S1= 7940&#177;3040 leuc&#243;citos/mm<sup><italic>3</italic></sup>; S2= 6950&#177; 2700/mm<sup><italic>3</italic></sup> (NS); S3= 10830&#177; 4690, (p&lt;0,001). Identificamos a dura&#231;&#227;o do procedimento (r=0,38, p&lt;0,05) e o volume total de soro glicosado (r=0,49, p&lt;0,05). S&#243;dio: S1= 134,5&#177;0,4mEq/L; S2= 130,7&#177;0,4mEq/L (p&lt;0,001) relacionado &#224; solu&#231;&#227;o glicosada (r=0,61, p&lt;0,01). Pot&#225;ssio: S1= 4,22&#177; 0,45mEq/L; S2= 3,83&#177;0,4mEq/L (p&lt;0,001). Nenhuma vari&#225;vel foi isolada. C&#225;lcio; S1= 9,13&#177;1,03mg%; S2= 8,4&#177;0,91mg% (relacionado ao ioxaglato r=0,43, p&lt;0,01). Osmolalidade: S1= 293,3&#177;12,5mOsm/kg; S2= 300,6&#177;13,3mOsm/kg (p&lt;0,001). Nenhuma das vari&#225;veis independentes foi isolada. Viscosidade: S1= 3,36&#177;0,81; S2= 3,09&#177;0,74 (p&lt;0,01); S3= 3,87&#177;0,89, p&lt;0,001 (devido a uma regress&#227;o linear indireta com o MC). </p>
    <p><bold><italic>CONCLUS&#195;O: </italic></bold>Varia&#231;&#245;es significativas nas vari&#225;veis dependentes medidas foram observadas durante e ap&#243;s o procedimento. O uso do ioxaglato foi parcialmente relacionado a mudan&#231;as no hemat&#243;crito/hemoglobina, c&#225;lcio total e viscosidade mas n&#227;o as das vari&#225;veis restantes. </p>
    <p><bold>Palavras-chave</bold>: meios de contraste, angiocardiografia, cardiologia pedi&#225;trica </p>
    <p>
      <bold>Blood Cell Count, Sodium, Potassium, Calcium, Osmolality and Viscosity, During Pediatric Angiocardiography with Ioxaglate </bold>
    </p>
    <p><bold><italic>PURPOSE: </italic></bold>Children's blood changes during angiocardiography may not be only due to the contrast media (CM). </p>
    <p><bold><italic>METHODS: </italic></bold>We studied the presence and severity of changes in those parameters in 35 pediatric patients undergoing angiocardiography with ioxaglate aiming to identify independent variables responsible for those changes. Blood samples were taken at the beginning of the procedure (S1), at the end (S2) and two hours later (S3). </p>
    <p><bold><italic>RESULTS: </italic></bold>Hematocrit: S1= 47.3&#177;6.9%; S2= 40.7&#177; 7.4% (p&lt;0.001), (related to the CM volume r=0.37, p&lt;0.05). Hemoglobin: S1= 15&#177;2.1g%; S2= 13.2&#177;2.4g% (p&lt;0.001), and S3= 12.7&#177;2.5g% (NS). White blood cell count: S1= 7940&#177;3040 leukocytes/mm<sup><italic>3</italic></sup>; S2= 6950&#177; 2700/mm<sup><italic>3</italic></sup> (NS); S3= 10830&#177;4690 leukocytes/mm<sup><italic>3</italic></sup>, (p&lt;0.001). Procedure duration (r=0.38, p&lt;0.05) and 5% glucose fluid given between S2 and S3 (r=0.49, p&lt;0.05) were isolated. Sodium: S1= 134.5&#177;0.4mEq/L; S2= 130.7&#177;0.4mEq/L (p&lt;0.001) (due to 5% glucose fluid injected, r=0.61, p&lt;0.01). Potassium: S1= 4.22&#177;0.45mEq/L, S2= 3.83&#177;0.4mEq/L (p&lt;0.001). Calcium: S1= 9.13&#177; 1.03mg%; S2= 8.4&#177;0.91mg/dL. (related to the CM, r=0.43, p&lt;0.01.) Osmolality: S1= 293.3&#177;12.5mOsm/kg; S2= 300.6&#177;13.3mOsm/kg (p&lt;0.001). Viscosity: S1= 3.36&#177;0.81; S2= 3.09&#177;0.74 (p&lt;0.01); S3= 3.87&#177;0.89, p&lt;0.001. There was an indirect linear regression with the CM. </p>
    <p><bold><italic>CONCLUSION: </italic></bold>There were profound differences among the dependent variables observed but the ioxaglate was partially related to changes in hematocrit/ hemoglobin, total calcium and viscosity. We failed to demonstrate significant regression coefficient between CM and changes in leukocytes, sodium, potassium, and osmolality. </p>
    <p><bold>Key-words</bold>: contrast media, angiocardiography, heart catheterization, pediatric cardiology </p>
    <p>Os meios de contraste (MC) s&#227;o formula&#231;&#245;es largamente utilizadas na angiocardiografia. Contudo, na medida que apresentam propriedades f&#237;sico-qu&#237;micas diferentes das do sangue, podem, ocasionalmente, trazer algum risco durante os procedimentos de cateteriza&#231;&#227;o card&#237;aca <sup>1</sup>. Isto &#233; particularmente verdadeiro, quando se trata de estudo hemodin&#226;mico em crian&#231;as, pois elas apresentam menores volumes sang&#252;&#237;neos, menor massa nos &#243;rg&#227;os de impacto, vasos e c&#226;maras card&#237;acas de paredes delgadas e, com freq&#252;&#234;ncia, est&#227;o funcionalmente comprometidas por cardiopatias cong&#234;nitas <sup>2</sup>. </p>
    <p>Poucos estudos descrevem os efeitos dos MC durante a angiocardiografia pedi&#225;trica. A maior parte deles descreve altera&#231;&#245;es em algumas vari&#225;veis, ocorridas imediatamente ap&#243;s a inje&#231;&#227;o do MC, quando o seu alto n&#237;vel no sangue &#233; comumente considerado respons&#225;vel pelas mudan&#231;as. Outros preocuparam-se com compara&#231;&#245;es entre diferentes tipos de MC <sup>3-21</sup>, mas, nenhum foi delineado para avaliar a interfer&#234;ncia de outras vari&#225;veis presentes durante a cateteriza&#231;&#227;o card&#237;aca. </p>
    <p>Propusemo-nos avaliar a presen&#231;a e a severidade das altera&#231;&#245;es nas seguintes vari&#225;veis dependentes: hemat&#243;crito, hemoglobina, leuc&#243;citos, s&#243;dio, pot&#225;ssio, c&#225;lcio, osmolalidade e viscosidade durante angiocardiografia com ioxaglato e, como objetivo secund&#225;rio, determinar quais das vari&#225;veis independentes, introduzidas durante o procedimento, foram respons&#225;veis por mudan&#231;as significativas nas m&#233;dias das vari&#225;veis dependentes. </p>
    <p>Foram consideradas vari&#225;veis independentes todas as condi&#231;&#245;es espec&#237;ficas, rotineiramente, associadas com cateteriza&#231;&#227;o card&#237;aca em crian&#231;as em nosso laborat&#243;rio, ou sejam: dura&#231;&#227;o do procedimento, volume do MC injetado, n&#250;mero de inje&#231;&#245;es do MC, volume de soro glicosado a 5% infundido durante e ap&#243;s o procedimento, volume de flu&#237;dos injetados durante e ap&#243;s o exame, tempo de jejum antes do exame e tempo total de jejum. </p>
    <p>M&#233;todos </p>
    <p>Delineamos um estudo observacional, prospectivo, anal&#237;tico, de dados pareados, para uma coorte de 35 crian&#231;as (22 meninos, 13 meninas), com idades entre 0-6 (m&#233;dia 2,42&#177;1,61) anos, e um peso m&#233;dio de 11,31&#177;5,13kg, encaminhadas ao procedimento angiocardiogr&#225;fico devido a cardiopatias cong&#234;nitas de uma forma seq&#252;encial. </p>
    <p>A <xref ref-type="table" rid="t1">tabela I</xref> mostra todas as crian&#231;as estudadas e as vari&#225;veis independentes observadas: idade, peso, tempo de jejum antes do procedimento, dura&#231;&#227;o do procedimento, n&#250;mero de inje&#231;&#245;es, volume total de MC (em ml e ml/kg) injetado em cada caso, e o volume de soro glicosado infundido durante e ap&#243;s o exame. A informa&#231;&#227;o acerca da quantidade de soro glicosado a 5% infundido foi coletada somente nos &#250;ltimos 21 casos ap&#243;s um estudo piloto dos primeiros 12 casos. An&#225;lise de regress&#227;o m&#250;ltipla foi aplicada nestes 21 casos. </p>
    <p content-type="asset">
      <table-wrap id="t1">
        <graphic xlink:href="1678-4170-abc-70-04-0257-00004-gt01.jpg"/></table-wrap>
    </p>
    <p>As crian&#231;as foram levadas &#224; sala de hemodin&#226;mica com um jejum m&#237;nimo de 6h (m&#233;dia 11,01&#177;2,05h - 1&#186; procedimento matutino), pr&#233; medicadas com cloridrato de morfina 0,2mg/kg e sulfato de atropina 0,01mg/kg, e todas submetidas a anestesia geral com entuba&#231;&#227;o orotraqueal e ventiladas num ambiente de O<sub>2</sub> a 100%, com isofluorane 0,5-1%. Uma veia perif&#233;rica foi puncionada para infundir solu&#231;&#227;o glicosada a 5%. O cateter (usualmente um NIH 7F) foi introduzido pela t&#233;cnica de Seldinger, a partir da veia femoral at&#233; o &#225;trio direito (AD). </p>
    <p>A 1&#170; amostra sang&#252;&#237;nea (S1) e a 2&#170; (S2) foram coletadas no AD. A 3&#170; (S3), foi obtida por pun&#231;&#227;o venosa 2h ap&#243;s o fim do exame, antes do in&#237;cio da alimenta&#231;&#227;o oral. Todas amostras foram coletadas com cuidado, com objetivo de evitar a contamina&#231;&#227;o do sangue por outras subst&#226;ncias. As amostras foram prontamente examinadas em nosso laborat&#243;rio de patologia cl&#237;nica. </p>
    <p>O MC usado foi o ioxaglato, um d&#237;mero i&#244;nico de baixa osmolalidade, considerado um dos mais adequados para angiocardiografia pedi&#225;trica <sup>5,12,17,22</sup>, contendo 19,6% de ioxaglato de s&#243;dio e 39,3% de ioxaglato de meglumina, cerca de 580mOsm/kg, 6 &#225;tomos de iodo para cada par de &#237;ons (raz&#227;o de iodo igual a 3), conte&#250;do de iodo igual a 320mg/ml, concentra&#231;&#227;o de iodo de 32% e concentra&#231;&#227;o da solu&#231;&#227;o de 59%. Seu conte&#250;do de s&#243;dio &#233; de 150mEq/L, viscosidade de 7,5 cps (5,8 em rela&#231;&#227;o &#224; &#225;gua) e &#233; aditivado com 0,2mg/ml de calciedetato de s&#243;dio <sup>24</sup>. </p>
    <p>S&#243;dio e pot&#225;ssio foram medidos por espectrofotometria e s&#227;o expressos em mEq/L. O c&#225;lcio total foi obtido pelo metiltimol e est&#225; expresso em mg%. A osmolalidade foi obtida pelo <italic>Advanced Osmometer</italic> 3W e seus resultados s&#227;o apresentados como mOsm/kg. A viscosidade foi determinada pelo viscos&#237;metro de Hess e sua unidade &#233; expressa em valores absolutos. Os leuc&#243;citos pelo <italic>ContCel-Counter</italic> D2. O hemat&#243;crito pelo IEC modelo MB, e a hemoglobina pelo <italic>Hemoglobinometer Coulter</italic> D2. </p>
    <p>As m&#233;dias dos dados pareados foram comparadas por an&#225;lise de vari&#226;ncia. Um valor de p&lt;0,05 foi considerado significante. V&#225;rias regress&#245;es lineares simples foram usadas para identificar as vari&#225;veis independentes, que influenciaram as altera&#231;&#245;es nas vari&#225;veis dependentes sob observa&#231;&#227;o. A an&#225;lise de regress&#227;o m&#250;ltipla foi aplicada nos &#250;ltimos 21 casos, nos quais disp&#250;nhamos do controle do volume da solu&#231;&#227;o glicosada a 5% infundida, assim como a contagem diferencial dos leuc&#243;citos (<xref ref-type="table" rid="t1">tab. I</xref>). Usamos o programa <italic>statgraphs </italic>2.0 da <italic>Statistical Graphics Corporation</italic>, USA, 1986, com inclus&#227;o passo a passo anter&#243;grada para detectar a presen&#231;a de algum modelo multivariado e para confirmar os resultados das correla&#231;&#245;es encontradas pela utiliza&#231;&#227;o da regress&#227;o linear simples. Para avaliar as diferen&#231;as significativas encontradas entre as m&#233;dias da S1, e da S2, (S1-S2), oferecemos como vari&#225;veis independentes: a dura&#231;&#227;o do procedimento (minutos); o volume de solu&#231;&#227;o glicosada a 5% infundida durante o exame em ml e ml/kg; o volume do MC em ml e ml/kg; a soma dos volumes do MC e flu&#237;dos dados durante o exame em ml/kg; tempo de jejum antes do procedimento; e tempo total de jejum. </p>
    <p>Para explicar as eventuais altera&#231;&#245;es entre as vari&#225;veis dependentes que ocorressem entre o S2 e S3 obtida 2h ap&#243;s seu final, oferecemos: a dura&#231;&#227;o do procedimento em minutos; volume do MC em ml/kg; e o total de soro glicosado dado ap&#243;s o exame em ml e ml/kg. </p>
    <p>As altera&#231;&#245;es das m&#233;dias das vari&#225;veis dependentes observadas entre S1 e S3, foram analisadas em fun&#231;&#227;o da: dura&#231;&#227;o do procedimento em minutos; volume total de flu&#237;dos infundidos durante e ap&#243;s o procedimento em ml e ml/kg; e, MC em ml/kg. A <xref ref-type="table" rid="t1">tabela I</xref> mostra os dados estat&#237;sticos das vari&#225;veis independentes. </p>
    <p>Resultados </p>
    <p>N&#227;o identificamos nenhum modelo multivariado. O uso da an&#225;lise de regress&#227;o m&#250;ltipla somente confirmou os dados encontrados com a regress&#227;o linear simples. </p>
    <p>A <xref ref-type="table" rid="t2">tabela II</xref> mostra as m&#233;dias das vari&#225;veis dependentes estudadas nos tr&#234;s momentos de coleta, e os resultados da ANOVA. O hemat&#243;crito que tinha um valor inicial de 47,3&#177;6,9% caiu para 40,7&#177;7,4% ao final do procedimento (p&lt;0,001), permanecendo neste n&#237;vel at&#233; 2h ap&#243;s, quando colhemos a &#250;ltima amostra (NS). Esta redu&#231;&#227;o de 14% no hemat&#243;crito &#233; parcialmente explicada pelo volume total do MC usado (r=0,37, p&lt;0,05). A hemoglobina mostrou-se uma vari&#225;vel interdependente do hemat&#243;crito com um coeficiente de Pearson quase perfeito (r=0,96, p&lt;0,001). Esta correla&#231;&#227;o permaneceu imut&#225;vel a despeito de todas as vari&#225;veis introduzidas durante o procedimento. Os valores da hemoglobina foram S1= 15&#177;2,1g%; S2= 13,2&#177;2,4g% (p&lt;0,001) e S3= 12,7&#177;2,5g% (NS) (<xref ref-type="fig" rid="f1">fig. 1</xref>). </p>
    <p content-type="asset">
      <table-wrap id="t2">
        <graphic xlink:href="1678-4170-abc-70-04-0257-00004-gt02.jpg"/></table-wrap>
    </p>
    <p content-type="asset">
      <fig id="f1">
        <graphic xlink:href="1678-4170-abc-70-04-0257-00004-gf01.jpg"/></fig>
    </p>
    <p>A m&#233;dia da contagem de leuc&#243;citos em S1 foi 7940&#177; 3040 leuc&#243;citos/mm<sup>3</sup> e em S2 6950&#177;2700/mm<sup>3</sup> (NS). Contudo, 2h ap&#243;s, encontramos uma m&#233;dia de 10830&#177;4690 leuc&#243;citos/mm<sup>3</sup>, (p&lt;0,001). Raz&#227;o que poderia ser explicada pela consistente correla&#231;&#227;o com o tempo despendido para a realiza&#231;&#227;o do procedimento (r= 0,38, p&lt;0,05). Tamb&#233;m encontramos correla&#231;&#227;o entre o sens&#237;vel aumento dos leuc&#243;citos e o total de solu&#231;&#227;o glicosada a 5% infundida no per&#237;odo S2 e 2h ap&#243;s S3 (r=0,49, p&lt;0,05 As diferen&#231;as das m&#233;dias das amostras S1 e S3 tamb&#233;m se correlacionaram, razoavelmente, com o tempo (minutos) de dura&#231;&#227;o do procedimento (r=0,56, p&lt;0,001). As c&#233;lulas respons&#225;veis por essas altera&#231;&#245;es foram os neutr&#243;filos segmentados e os linf&#243;citos. Na <xref ref-type="fig" rid="figura2">figura 2</xref> apresentamos as m&#233;dias dos leuc&#243;citos bem como as correla&#231;&#245;es com a dura&#231;&#227;o do procedimento e o volume de solu&#231;&#227;o glicosada a 5% infundida. </p>
    <fig id="figura2">
      <graphic xlink:href="1678-4170-abc-70-04-0257-00004-gf02.jpg"/></fig>
    <p>S&#243;dio, pot&#225;ssio e c&#225;lcio mostraram a mesma intensidade e sentido nas varia&#231;&#245;es, mas por diferentes raz&#245;es: eles ca&#237;ram significativamente durante o procedimento (entre S1 e S2) e retornaram aos n&#237;veis iniciais 2h ap&#243;s em S3. O s&#243;dio, de uma m&#233;dia inicial de (S1<italic>)</italic> 134,5&#177;0,4mEq/L reduziu-se at&#233; (S2) 130,7&#177;0,4mEq/L no fim do exame (p&lt;0,001). Detectamos que esta correla&#231;&#227;o (r=0,61, p&lt;0,01) teria ocorrido em vista do total de solu&#231;&#227;o glicosada a 5% infundida (14,34&#177;11,48ml/kg) no decorrer do procedimento. Este volume infundido sofreu redu&#231;&#227;o no intervalo entre as amostras S2 e S3 (5,2&#177;3,43ml/kg) (<xref ref-type="table" rid="t1">tab. I</xref> e <xref ref-type="table" rid="t2">II</xref>). O pot&#225;ssio foi de 4,22&#177;0,45mEq/L em S1, para 3,83&#177;0,4mEq/L (p&lt;0,001) em S2. N&#227;o identificamos nenhuma vari&#225;vel independente respons&#225;vel por esta varia&#231;&#227;o. O valor m&#233;dio do c&#225;lcio total foi de 9,13&#177;1,03mg% em S1, caindo para 8,4&#177;0,91mg% em S2 ao final do procedimento. A varia&#231;&#227;o das m&#233;dias entre S1 e S2 foi correlacionada ao volume do MC (r=0,43, p&lt;0,01). A <xref ref-type="fig" rid="figura3">figura 3</xref> mostra estas altera&#231;&#245;es i&#244;nicas e tamb&#233;m o gr&#225;fico de regress&#227;o linear entre o decr&#233;scimo do c&#225;lcio (S1-S2) e o volume do MC (ml/kg). </p>
    <fig id="figura3">
      <graphic xlink:href="1678-4170-abc-70-04-0257-00004-gf03.jpg"/></fig>
    <p>A osmolalidade subiu de 293,3&#177;12,5mOsm/kg (S1), para 300,6&#177;13,3mOsm/kg (S2) (p&lt;0,001). Nenhuma vari&#225;vel independente foi isolada para explicar este incremento de 2,5%. Duas horas ap&#243;s o fim do procedimento a osmolalidade m&#233;dia foi 286,6&#177;20,1mOsm/kg (S3); quando comparado com o S1 e com S2, encontramos signific&#226;ncia (p&lt;0,001), demonstrando que as altera&#231;&#245;es na osmolalidade devem ser uma resultante final de v&#225;rios outros fatores, tais como: medida da osmolalidade ao final do procedimento (S2) que levou em m&#233;dia 74,1&#177;23,1min para ser efetuado; solu&#231;&#227;o glicosada diluindo o s&#243;dio s&#233;rico; e baixa osmolalidade do MC usado. O volume total de flu&#237;dos injetados (volume de MC injetado + volume de solu&#231;&#227;o glicosada 5%) mostrou um coeficiente de correla&#231;&#227;o r=0,34, NS . </p>
    <p>A viscosidade era em S1= 3,36&#177;0,81, em S2= 3,09&#177;0,74 (p&lt;0,01) e em S3, mostrou um aumento de 15,5% (3,87&#177;0,89, p&lt;0,001) sobre o valor S1. Encontramos um regress&#227;o linear indireta, ou inversa com o MC, ao se analisar as diferen&#231;as entre as m&#233;dias S1 e S3 (r=0,39, p &lt; 0,05, n=35). Desta forma, a viscosidade ao tempo da S3, s&#243; n&#227;o alcan&#231;ou n&#237;veis mais elevados devido &#224; a&#231;&#227;o do MC, que atua de forma inversa por deixar o hemat&#243;crito (principal componente da viscosidade sang&#252;&#237;nea) mais baixo (<xref ref-type="fig" rid="f1">fig. 1B</xref> e <xref ref-type="fig" rid="f1">1D</xref>). N&#227;o identificamos nenhuma vari&#225;vel independente relacionada &#224;s diferen&#231;as entre as m&#233;dias S1 e S2 e entre S2 e S3. </p>
    <p>Discuss&#227;o </p>
    <p>Comumente, estudos sobre MC n&#227;o consideram todas as vari&#225;veis (independentes), inerentes &#224; da rotina de cada procedimento. Pretend&#237;amos estudar a exist&#234;ncia e amplitude de varia&#231;&#227;o nas m&#233;dias das vari&#225;veis dependentes e, tamb&#233;m, verificar quais vari&#225;veis independentes respons&#225;veis por tais altera&#231;&#245;es. O volume total de solu&#231;&#227;o glicosada a 5% infundida n&#227;o foi controlado nos pacientes 1 a 14. Assim, a an&#225;lise de regress&#227;o m&#250;ltipla s&#243; p&#244;de ser aplicada nos casos 15 a 35 (21 casos). Contudo todos os dados foram submetidos a ANOVA e m&#250;ltiplas regress&#245;es lineares simples, com objetivo de confirmar os resultados da regress&#227;o m&#250;ltipla. Como n&#227;o se estabeleceu nenhum modelo multivariado, a regress&#227;o m&#250;ltipla somente coincidiu com os resultados da regress&#227;o linear univariada. </p>
    <p>Confirmamos que o hemat&#243;crito e a hemoglobina eram vari&#225;veis interdependentes <sup>23</sup>,uma vez que ambos mostraram varia&#231;&#245;es no mesmo sentido e com a mesma intensidade e um elevado coeficiente de correla&#231;&#227;o (r=0,96; <xref ref-type="fig" rid="f1">fig. 1A</xref>). Suas m&#233;dias ca&#237;ram 14% durante o procedimento (S1-S2), o que foi consistente com o j&#225; descrito na literatura <sup>3,5,11</sup>. Esta mudan&#231;a &#233; atribu&#237;da a desidrata&#231;&#227;o dos eritr&#243;citos e, secundariamente, ao aumento do volume plasm&#225;tico, a partir do espa&#231;o extravascular. O aumento da osmolalidade tem sido reconhecido como respons&#225;vel por esses fen&#244;menos <sup>3,11,24</sup>. A vari&#225;vel volume do ioxaglato injetado (ml/kg) demonstrou um coeficiente de correla&#231;&#227;o (r=0,37; p&lt;0,05) com o decr&#233;scimo das m&#233;dias do hemat&#243;crito/hemoglobina (ml/kg) (<xref ref-type="fig" rid="f1">fig. 1D</xref>). Esper&#225;vamos que o volume de soluto glicosado a 5%, infundido durante o procedimento (m&#233;dia 14,3&#177;11,48ml/kg), reduzisse o hemat&#243;crito/hemoglobina por efeito dilucional, no entanto, n&#227;o foi encontrada correla&#231;&#227;o significativa. Uma vez que os valores das m&#233;dias do hemat&#243;crito e hemoglobina permaneceram abaixo do n&#237;vel inicial em S3, presumimos que perdas sang&#252;&#237;neas (que n&#227;o foram controladas durante o procedimento), pudessem ser parcialmente respons&#225;veis por esses achados. </p>
    <p>Em 1981, Cumberland <sup>5</sup> mostrou uma redu&#231;&#227;o de 11% nos leuc&#243;citos ap&#243;s o uso de ioxaglato em 10 crian&#231;as. Confirmamos uma redu&#231;&#227;o n&#227;o significativa (12,5%) em S2 e um significativo e inesperado aumento (56%) (p&lt;0,001) em S3, quando se compararam os valores das m&#233;dias entre a S2 e S3. Isto se deveu principalmente aos neutr&#243;filos segmentados e aos linf&#243;citos. A dura&#231;&#227;o (minutos) do procedimento foi identificada como sendo a vari&#225;vel independente respons&#225;vel por este aumento (56%) com uma correla&#231;&#227;o fraca, mas significativa (r=0,38, p&lt;0,05, n=35) ao se considerar S2-S3. Isto se torna mais intenso quando consideramos as diferen&#231;as das m&#233;dias dos leuc&#243;citos entre S1-S3 (r=0,56, p&lt;0,001, n=35). N&#227;o encontramos na literatura qualquer men&#231;&#227;o a achado semelhante a este e supusemos que isto pudesse representar uma rea&#231;&#227;o ao car&#225;ter invasivo do procedimento. A infus&#227;o da solu&#231;&#227;o glicosada foi tamb&#233;m isolada e relacionada com o aumento dos leuc&#243;citos (r=0,49, p&lt;0,05, n=21) ao se tomar as diferen&#231;as entre as m&#233;dias S2 e S3. N&#227;o conseguimos explicar tal achado. De qualquer forma, o conhecimento de que ocorre um aumento dos leuc&#243;citos &#233; um achado particularmente relevante, uma vez que a constata&#231;&#227;o de sua eleva&#231;&#227;o sempre nos leva a suspeitar de algum processo infeccioso. </p>
    <p>O &#237;on s&#243;dio caiu 2,9% entre S1 e S2, tendo sido encontrada forte correla&#231;&#227;o desse achado com o volume total de solu&#231;&#227;o glicosada infundida durante o procedimento, mas n&#227;o ao volume do MC injetado. O efeito dilucional pode explicar este achado. Outros estudos n&#227;o encontraram altera&#231;&#245;es significativas neste &#237;on <sup>3,6,25</sup> em parte, provavelmente, devido ao seu alto coeficiente de difus&#227;o nos leitos capilares e, por outro lado, devido a diferentes rotinas de execu&#231;&#227;o do procedimento em diversos laborat&#243;rios. O &#237;on pot&#225;ssio caiu 10% (S1-S2) e n&#227;o conseguimos isolar qualquer vari&#225;vel independente para explicar este fato. Levin <sup>3</sup> e col encontraram uma redu&#231;&#227;o significativa nos primeiros 5min ap&#243;s uma inje&#231;&#227;o com um MC de alta osmolalidade. </p>
    <p>A diminui&#231;&#227;o do n&#237;vel de c&#225;lcio (S1-S2) e a identifica&#231;&#227;o do MC como a vari&#225;vel independente respons&#225;vel por este achado foi uma surpresa, j&#225; que este MC &#233; tido como n&#227;o quelante, uma vez que tem em sua formula&#231;&#227;o 0,2mg/ml de calciedetato diss&#243;dico. N&#227;o podemos afirmar se a ionicidade do ioxaglato ou uma baixa concentra&#231;&#227;o do anticoagulante foi respons&#225;vel por este achado. Uma redu&#231;&#227;o transit&#243;ria no n&#237;vel de c&#225;lcio &#233; esperada ao se usar um MC com alta osmolalidade, i&#244;nico e sem c&#225;lcio <sup>25,26</sup>. </p>
    <p>A osmolalidade nas crian&#231;as, comumente entre 287&#177;6mOsm/kg <sup>6</sup>, mostrou um aumento de 2,5% (S1-S2). Duas horas ap&#243;s, uma redu&#231;&#227;o de 2,3% (S1-S3). Cumberland <sup>5</sup> encontrou um aumento da osmolalidade de 1,5% em 10 crian&#231;as ap&#243;s terem recebido uma inje&#231;&#227;o de ioxaglato. A falta de correla&#231;&#227;o entre este MC e as altera&#231;&#245;es na osmolalidade foi provavelmente devido a v&#225;rios fatores: o volume de solu&#231;&#227;o glicosada infundida durante o exame (14,33&#177;11,48ml/kg); a medida da osmolalidade s&#243; ao fim do procedimento (S2) (dura&#231;&#227;o m&#233;dia de 74,1&#177;23,2min); a baixa osmolalidade do ioxaglato (590,8mOsm/kg); e a redu&#231;&#227;o do s&#243;dio encontrada ao fim do procedimento. No entanto, uma redu&#231;&#227;o de todas vari&#225;veis dependentes, ocorrendo ao mesmo tempo, em que havia um aumento da osmolalidade, sugere um efeito dilucional. </p>
    <p>A viscosidade do ioxaglato era 5,8&#177;0,3, enquanto que a do sangue, em S1 era 3,36&#177;0,81. Desta forma, era de se esperar um aumento da viscosidade ao fim do procedimento. No entanto, o que encontramos foi uma queda de 7,8% entre S1 e S2. O volume de soro infundido (ml/kg) esbo&#231;ou um coeficiente de correla&#231;&#227;o de 0,39, (NS). Em S3, encontramos um aumento de 25% na viscosidade. Nenhuma vari&#225;vel independente foi correlacionada com este achado. J&#225; ao se cotejar as diferen&#231;as entre as m&#233;dias de S1 e S3), identificamos o MC (ml/kg) com uma correla&#231;&#227;o indireta (r=0,39: p&lt;0,05<italic>)</italic>. Aparentemente o ioxaglato reduz a viscosidade ao reduzir o hemat&#243;crito, seu componente principal. </p>
    <p>Conclu&#237;mos para um n&#237;vel de signific&#226;ncia de p&lt;0,05 que houve altera&#231;&#245;es nas vari&#225;veis dependentes-hemat&#243;crito, hemoglobina, leuc&#243;citos, s&#243;dio, pot&#225;ssio, c&#225;lcio, viscosidade e osmolalidade e que o ioxaglato foi isolado e relacionado &#224;quelas encontradas no hemat&#243;crito/hemoglobina, c&#225;lcio e viscosidade, apesar de n&#227;o explicar totalmente suas varia&#231;&#245;es. </p>
    <p>As altera&#231;&#245;es encontradas nos leuc&#243;citos foram, principalmente, relacionadas &#224; dura&#231;&#227;o do procedimento e as do s&#243;dio &#224; infus&#227;o de solu&#231;&#227;o glicosada. Nenhuma vari&#225;vel independente foi identificada como respons&#225;vel por altera&#231;&#245;es na osmolalidade plasm&#225;tica ou do pot&#225;ssio. </p>
    <p>Instituto de Cardiologia do Rio Grande do Sul/Funda&#231;&#227;o Universit&#225;ria de Cardiologia </p>
    <p> Correspond&#234;ncia: Mauro Regis S. Moura - Instituto de Cardiologia do RS/FUC - Unidade de Pesquisa - Av. Princesa Isabel, 395 - 90620-001 - Porto Alegre, RS </p>
    <p> Recebido para publica&#231;&#227;o em 7/1/98 </p>
    <p> Aceito em 4/2/98 </p>
  </body>
  <back>
    <ref-list>
      <ref id="B1">
        <label>1</label>
        <mixed-citation>1. Dawson P - Cardiovascular effects of contrast agents. Am J Cardiol 1989; 64: 2E-9E.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Cardiovascular effects of contrast agents</article-title>
          <source>Am J Cardiol</source>
          <date>
            <year>1989</year>
          </date>
          <fpage>2E</fpage>
          <lpage>9E</lpage>
          <volume>64</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Dawson</surname>
              <given-names>P</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B2">
        <label>2</label>
        <mixed-citation>2. Krovetz LJ, Shanklin DR, Schiebler GL - Serious and fatal complications of catheterization and angiocardiography in infants and children. Am Heart J<bold> </bold>1968; 76: 39-47.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Serious and fatal complications of catheterization and angiocardiography in infants and children</article-title>
          <source>Am Heart J</source>
          <date>
            <year>1968</year>
          </date>
          <fpage>39</fpage>
          <lpage>47</lpage>
          <volume>76</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Krovetz</surname>
              <given-names>LJ</given-names>
            </name>
            <name>
              <surname>Shanklin</surname>
              <given-names>DR</given-names>
            </name>
            <name>
              <surname>Schiebler</surname>
              <given-names>GL</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B3">
        <label>3</label>
        <mixed-citation>3. Levin AR, Grosman H, Schubert ET, Winchester P, Gilladoga A - Effect of angiocardiography on fluid and electrolyte balance. J Roentgenol 1969; 105: 777-83.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Effect of angiocardiography on fluid and electrolyte balance</article-title>
          <source>J Roentgenol</source>
          <date>
            <year>1969</year>
          </date>
          <fpage>777</fpage>
          <lpage>83</lpage>
          <volume>105</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Levin</surname>
              <given-names>AR</given-names>
            </name>
            <name>
              <surname>Grosman</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Schubert</surname>
              <given-names>ET</given-names>
            </name>
            <name>
              <surname>Winchester</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Gilladoga</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B4">
        <label>4</label>
        <mixed-citation>4. Brown R, Rahimtoola SH, Davis GD, Swan HJC - The effect of angiocardiographic contrast medium on circulatory dynamics in man: cardiac output during angiocardiography. Circulation 1965; 31: 234-40.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>The effect of angiocardiographic contrast medium on circulatory dynamics in man: cardiac output during angiocardiography</article-title>
          <source>Circulation</source>
          <date>
            <year>1965</year>
          </date>
          <fpage>234</fpage>
          <lpage>40</lpage>
          <volume>31</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Brown</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Rahimtoola</surname>
              <given-names>SH</given-names>
            </name>
            <name>
              <surname>Davis</surname>
              <given-names>GD</given-names>
            </name>
            <name>
              <surname>Swan</surname>
              <given-names>HJC</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B5">
        <label>5</label>
        <mixed-citation>5. Cumberland DC - Hexabrix a new contrast medium in angiocardiography. Br Heart J<bold> </bold>1981; 45: 698-702.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Hexabrix a new contrast medium in angiocardiography</article-title>
          <source>Br Heart J</source>
          <date>
            <year>1981</year>
          </date>
          <fpage>698</fpage>
          <lpage>702</lpage>
          <volume>45</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Cumberland</surname>
              <given-names>DC</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B6">
        <label>6</label>
        <mixed-citation>6. Giammona ST, Lurie PR, Segar WE - Hypertonicity following selective angiocardiography. Circulation<bold> </bold>1963; 28: 1096-101.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Hypertonicity following selective angiocardiography</article-title>
          <source>Circulation</source>
          <date>
            <year>1963</year>
          </date>
          <fpage>1096</fpage>
          <lpage>101</lpage>
          <volume>28</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Giammona</surname>
              <given-names>ST</given-names>
            </name>
            <name>
              <surname>Lurie</surname>
              <given-names>PR</given-names>
            </name>
            <name>
              <surname>Segar</surname>
              <given-names>WE</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B7">
        <label>7</label>
        <mixed-citation>7. Altman AR, Kahn RE, Borrelli FJ - Fifty per cent sodium diatrizoate for selective angiocardiography in infants complications avoided by use of a low viscosity and low osmolarity contrast medium. Angiology<bold> </bold>1967; 18: 150-5.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Fifty per cent sodium diatrizoate for selective angiocardiography in infants complications avoided by use of a low viscosity and low osmolarity contrast medium</article-title>
          <source>Angiology</source>
          <date>
            <year>1967</year>
          </date>
          <fpage>150</fpage>
          <lpage>5</lpage>
          <volume>18</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Altman</surname>
              <given-names>AR</given-names>
            </name>
            <name>
              <surname>Kahn</surname>
              <given-names>RE</given-names>
            </name>
            <name>
              <surname>Borrelli</surname>
              <given-names>FJ</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B8">
        <label>8</label>
        <mixed-citation>8. Krovetz LJ, Shanklin DR, Schiebler GL - Serious and fatal complications of catheterization and angiocardiography in infants and children. Am Heart J<bold> </bold>1968; 76: 39-47.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Serious and fatal complications of catheterization and angiocardiography in infants and children</article-title>
          <source>Am Heart J</source>
          <date>
            <year>1968</year>
          </date>
          <fpage>39</fpage>
          <lpage>47</lpage>
          <volume>76</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Krovetz</surname>
              <given-names>LJ</given-names>
            </name>
            <name>
              <surname>Shanklin</surname>
              <given-names>DR</given-names>
            </name>
            <name>
              <surname>Schiebler</surname>
              <given-names>GL</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B9">
        <label>9</label>
        <mixed-citation>9. Krovetz LJ, Grumbar PA, Hardin S, Morgan AV, Schiebler GL - Complications folllowing use of four angiocardiographic contrast media in infants and children. Invest Radiol<bold> </bold>1969; 4: 13-8.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Complications folllowing use of four angiocardiographic contrast media in infants and children</article-title>
          <source>Invest Radiol</source>
          <date>
            <year>1969</year>
          </date>
          <fpage>13</fpage>
          <lpage>8</lpage>
          <volume>4</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Krovetz</surname>
              <given-names>LJ</given-names>
            </name>
            <name>
              <surname>Grumbar</surname>
              <given-names>PA</given-names>
            </name>
            <name>
              <surname>Hardin</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Morgan</surname>
              <given-names>AV</given-names>
            </name>
            <name>
              <surname>Schiebler</surname>
              <given-names>GL</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B10">
        <label>10</label>
        <mixed-citation>10. Srouji MN, Rashkind W - The effect of cardiac catheterization on the acid base status of infants with congenital heart disease. Pediatrics<bold> </bold>1969; 75: 943-51.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>The effect of cardiac catheterization on the acid base status of infants with congenital heart disease</article-title>
          <source>Pediatrics</source>
          <date>
            <year>1969</year>
          </date>
          <fpage>943</fpage>
          <lpage>51</lpage>
          <volume>75</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Srouji</surname>
              <given-names>MN</given-names>
            </name>
            <name>
              <surname>Rashkind</surname>
              <given-names>W</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B11">
        <label>11</label>
        <mixed-citation>11. Lachlan H - Biochemical and other changes occurring in infants during angiocardiography. Proc Roy Soc Med 1970; 63: 10-3.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Biochemical and other changes occurring in infants during angiocardiography</article-title>
          <source>Proc Roy Soc Med</source>
          <date>
            <year>1970</year>
          </date>
          <fpage>10</fpage>
          <lpage>3</lpage>
          <volume>63</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Lachlan</surname>
              <given-names>H</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B12">
        <label>12</label>
        <mixed-citation>12. Leriche H, Demanton S, Losay J - Cardiopathies cong&#233;nitales et produits de contraste. Essais d'un nouvel opacifiant. Coeur 1981; 12: 261-4.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Cardiopathies cong&#233;nitales et produits de contraste: Essais d'un nouvel opacifiant</article-title>
          <source>Coeur</source>
          <date>
            <year>1981</year>
          </date>
          <fpage>261</fpage>
          <lpage>4</lpage>
          <volume>12</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Leriche</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Demanton</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Losay</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B13">
        <label>13</label>
        <mixed-citation>13. Nikula E, Kiviniitty K - Cytogenic effects of cardioangiography on blood lymphocytes in children and in vitro effects of contrast medium and low dose radiation. Acta Oncol. 1987; 26: 69-74.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Cytogenic effects of cardioangiography on blood lymphocytes in children and in vitro effects of contrast medium and low dose radiation</article-title>
          <source>Acta Oncol</source>
          <date>
            <year>1987</year>
          </date>
          <fpage>69</fpage>
          <lpage>74</lpage>
          <volume>26</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Nikula</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Kiviniitty</surname>
              <given-names>K</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B14">
        <label>14</label>
        <mixed-citation>14. Saito H, Kimura K, Takamiya M et al - Comparison of ionic and nonionic low osmolar contrast media in coronary arteriography a crossover study in children. Invest Radiol<bold> </bold>1988; 23: 910-3.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Comparison of ionic and nonionic low osmolar contrast media in coronary arteriography a crossover study in children</article-title>
          <source>Invest Radiol</source>
          <date>
            <year>1988</year>
          </date>
          <fpage>910</fpage>
          <lpage>3</lpage>
          <volume>23</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Saito</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Kimura</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Takamiya</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B15">
        <label>15</label>
        <mixed-citation>15. Rubin CM, Ogilvie BC, Keeton BR - Comparison of low-osmolar contrast media in paediatric cardiac angiography. Br J Radiol 1987; 60: 133-5.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Comparison of low-osmolar contrast media in paediatric cardiac angiography</article-title>
          <source>Br J Radiol</source>
          <date>
            <year>1987</year>
          </date>
          <fpage>133</fpage>
          <lpage>5</lpage>
          <volume>60</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Rubin</surname>
              <given-names>CM</given-names>
            </name>
            <name>
              <surname>Ogilvie</surname>
              <given-names>BC</given-names>
            </name>
            <name>
              <surname>Keeton</surname>
              <given-names>BR</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B16">
        <label>16</label>
        <mixed-citation>16. Gliech V, Goldner B, Gola G, Munster W, Kothe K - A double-blind randomized comparative study of iopromide and amidotrizoate in the angiocardiography of infants and young children with congenital heart defects. Radiol Diagn Berl 1989; 30: 328-32.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>A double-blind randomized comparative study of iopromide and amidotrizoate in the angiocardiography of infants and young children with congenital heart defects</article-title>
          <source>Radiol Diagn Berl</source>
          <date>
            <year>1989</year>
          </date>
          <fpage>328</fpage>
          <lpage>32</lpage>
          <volume>30</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Gliech</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Goldner</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Gola</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Munster</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Kothe</surname>
              <given-names>K</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B17">
        <label>17</label>
        <mixed-citation>17. Amiel M, Revel D - Pediatric angiocardiography. Randomized, controlled study of 2 iodinated contrast media: iopromide 300 and ioxaglate 320mgi/ml. Ann Radiol Paris 1989; 32: 336-8.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Pediatric angiocardiography. Randomized, controlled study of 2 iodinated contrast media: iopromide 300 and ioxaglate 320mgi/ml</article-title>
          <source>Ann Radiol Paris</source>
          <date>
            <year>1989</year>
          </date>
          <fpage>336</fpage>
          <lpage>8</lpage>
          <volume>32</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Amiel</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Revel</surname>
              <given-names>D</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B18">
        <label>18</label>
        <mixed-citation>18. Pelech NA, Allard SM, Hurd RT, Giddins NG, Collins GF - A comparison of iohexol and diatrizoate-meglumine in children undergoing cardiac catheterization. Invest Radiol 199; 26: 665-70.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>A comparison of iohexol and diatrizoate-meglumine in children undergoing cardiac catheterization</article-title>
          <source>Invest Radiol</source>
          <fpage>665</fpage>
          <lpage>70</lpage>
          <volume>26</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Pelech</surname>
              <given-names>NA</given-names>
            </name>
            <name>
              <surname>Allard</surname>
              <given-names>SM</given-names>
            </name>
            <name>
              <surname>Hurd</surname>
              <given-names>RT</given-names>
            </name>
            <name>
              <surname>Giddins</surname>
              <given-names>NG</given-names>
            </name>
            <name>
              <surname>Collins</surname>
              <given-names>GF</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B19">
        <label>19</label>
        <mixed-citation>19. Hentschel M, Gildein P, Brandis M, Zimmerhackl LB - Endothelin (ET-1) is involved in the contrast media induced nephrotoxicity in children with congenital heart disease. Clin Nephrol 1995; 43(suppl 1): S12-15.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Endothelin (ET-1) is involved in the contrast media induced nephrotoxicity in children with congenital heart disease</article-title>
          <source>Clin Nephrol</source>
          <date>
            <year>1995</year>
          </date>
          <fpage>S12</fpage>
          <lpage>15</lpage>
          <volume>43</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Hentschel</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Gildein</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Brandis</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Zimmerhackl</surname>
              <given-names>LB</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B20">
        <label>20</label>
        <mixed-citation>20. Kavukcu S, Tavli V, Fadiloglu M, Akhunlar H, Oran B, Akcoral A - Urinary enzyme changes in children undergoing cineangiographic evaluation using iopromid. Int Urol Nephrol. 1995; 27: 131-5.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Urinary enzyme changes in children undergoing cineangiographic evaluation using iopromid</article-title>
          <source>Int Urol Nephrol.</source>
          <date>
            <year>1995</year>
          </date>
          <fpage>131</fpage>
          <lpage>5</lpage>
          <volume>27</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Kavukcu</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Tavli</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Fadiloglu</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Akhunlar</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Oran</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Akcoral</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B21">
        <label>21</label>
        <mixed-citation>21. Rossignol AM, Lusson JR, Chantepie A, Losay J - Safety and efficacy of xenetix, a new iodinated contrast agent, in pediatric angiocardiography. Acta Radiol 1996; 400(suppl): 81-4.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Safety and efficacy of xenetix, a new iodinated contrast agent, in pediatric angiocardiography</article-title>
          <source>Acta Radiol</source>
          <date>
            <year>1996</year>
          </date>
          <fpage>81</fpage>
          <lpage>4</lpage>
          <volume>400</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Rossignol</surname>
              <given-names>AM</given-names>
            </name>
            <name>
              <surname>Lusson</surname>
              <given-names>JR</given-names>
            </name>
            <name>
              <surname>Chantepie</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Losay</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B22">
        <label>22</label>
        <mixed-citation>22. Tsch&#228;ppeler H - Ioxaglate as contrast medium in pediatric urography. Eur Soc Ped Radiol 1980; 24: 105-8.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Ioxaglate as contrast medium in pediatric urography</article-title>
          <source>Eur Soc Ped Radiol</source>
          <date>
            <year>1980</year>
          </date>
          <fpage>105</fpage>
          <lpage>8</lpage>
          <volume>24</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Tsch&#228;ppeler</surname>
              <given-names>H</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B23">
        <label>23</label>
        <mixed-citation>23. Daniel MK, Bennett B, Dawson AA, Rawles JM - Haemoglobin concentration and linear cardiac output, peripheral resistence, and oxygen transport. Br Med J 1986; 292: 923-6.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Haemoglobin concentration and linear cardiac output, peripheral resistence, and oxygen transport</article-title>
          <source>Br Med J</source>
          <date>
            <year>1986</year>
          </date>
          <fpage>923</fpage>
          <lpage>6</lpage>
          <volume>292</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Daniel</surname>
              <given-names>MK</given-names>
            </name>
            <name>
              <surname>Bennett</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Dawson</surname>
              <given-names>AA</given-names>
            </name>
            <name>
              <surname>Rawles</surname>
              <given-names>JM</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B24">
        <label>24</label>
        <mixed-citation>24. Hirshfeld JW, Laskey W, Martin JL, Groh WC, Untereker W, Wolf GL - Hemodynamic changes induced by cardiac angiography with ioxaglate: comparison with diatrizoate. J Am Coll Cardiol 1983; 2: 954-7.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Hemodynamic changes induced by cardiac angiography with ioxaglate: comparison with diatrizoate</article-title>
          <source>J Am Coll Cardiol</source>
          <date>
            <year>1983</year>
          </date>
          <fpage>954</fpage>
          <lpage>7</lpage>
          <volume>2</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Hirshfeld</surname>
              <given-names>JW</given-names>
            </name>
            <name>
              <surname>Laskey</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Martin</surname>
              <given-names>JL</given-names>
            </name>
            <name>
              <surname>Groh</surname>
              <given-names>WC</given-names>
            </name>
            <name>
              <surname>Untereker</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Wolf</surname>
              <given-names>GL</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B25">
        <label>25</label>
        <mixed-citation>25. Caufield JB, Zir L, Harthorne JW - Blood calcium levels in the presence of arteriographic contrast material. Circulation 1975; 52: 119-23.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Blood calcium levels in the presence of arteriographic contrast material</article-title>
          <source>Circulation</source>
          <date>
            <year>1975</year>
          </date>
          <fpage>119</fpage>
          <lpage>23</lpage>
          <volume>52</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Caufield</surname>
              <given-names>JB</given-names>
            </name>
            <name>
              <surname>Zir</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Harthorne</surname>
              <given-names>JW</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B26">
        <label>26</label>
        <mixed-citation>26. Morris TW, Sahler LG, Fischer HW - Calcium binding by radiopaque media. Invest Radiol 1982; 17: 501-5.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Calcium binding by radiopaque media</article-title>
          <source>Invest Radiol</source>
          <date>
            <year>1982</year>
          </date>
          <fpage>501</fpage>
          <lpage>5</lpage>
          <volume>17</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Morris</surname>
              <given-names>TW</given-names>
            </name>
            <name>
              <surname>Sahler</surname>
              <given-names>LG</given-names>
            </name>
            <name>
              <surname>Fischer</surname>
              <given-names>HW</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
    </ref-list>
  </back>
</article>
